The Urological Tumour Committee is made up of a multidisciplinary team of professionals in: urology, medical oncology, radiation oncology, pathological anatomy, radiology, molecular biology, psychology, and nursing.
The treatment of a urological tumour will depend on its typology, extension, and evolution. Depending on each case, there are therapeutic options available for surgery, external or internal radiotherapy (brachytherapy), or systemic treatments (chemotherapy, hormone therapy, drugs against molecular targets, etc.) and/or combinations of these.
The urological tumours committee deals with cancers related to the urology speciality.
Prostate cancer is a disease in which malignant cells form in the tissues of the prostate.
Testicular cancer occurs in the testicles, the sperm-producing male gonads.
Bladder cancer occurs when the cells that make up the urinary bladder grow out of control.
Kidney cancer is a type of cancer that originates in the kidneys, the main organs of the urinary system.
Services included in this committee
The Tumour Committees are regulated under established protocols and are made up of a multidisciplinary team of expert doctors from the main specialities depending on the type of tumour. The IVO’s urological tumour committee is made up of multidisciplinary medical teams from the following specialities: